Dec 7 2009
BioMedReports.Com, the news portal which
covers Wall Street's biomedical sector and delivers financial and
investment intelligence to a community of highly informed investors, has
issued a special interview with the management team from MedClean
Technologies (OTCBB: MCLN).
Last week, BioMedReports readers were introduced to MedClean Technologies,
a company who provides on-site treatment solutions and fixed installations
that fit within healthcare institutions while saving those hospitals and
clinics a great deal of money, paperwork and resources usually allocated
towards the handling of medical waste.
"Based on the interviews, company filings and financial results, we see
that the experienced management team of this company is doing an
outstanding job of securing a position that provides a base for further
advancement in this lucrative, yet equally competitive regulated medical
waste sector where company shares often trade at 14-25x earnings," writes
M.E. Garza of BioMedreports. "It became very clear to us that shares of the
company are trading at a vastly undervalued price point and that this is a
tremendous opportunity for serious investors to consider."
As MedClean's Chairman Scott Grisanti points out during the exclusive
interview, "The market opportunity in the U.S. medical waste market is two
billion dollars a year... Without a doubt, there is tremendous opportunity
in this market for onsite treatment of regulated medical waste, even if you
set aside for a moment the HIPPA compliant destruction of confidential
documents.
"Several billion dollars a year are spent in the offsite hauling of
regulated medical waste, so there is tremendous market opportunity. So the
companies in the market for onsite treatment of waste are small and
fragmented. The good news in this is that it is a largely untapped market.
So this is a multibillion dollar market opportunity that renews every year.
The hospitals never stop making infectious waste. So, it is a very
underpenetrated market and no company has emerged with the capability and
scalability to be a significant player and we need to be that significant
player."
The complete interview is available now at BioMedReports.Com:
http://biomedreports.com/component/content/article/56-top-leading-news/20594-part-ii-medclean-prepared-for-more-growth.html
SOURCE: BioMedReports.Com